References
- FlatzLConradCRole of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapyPsoriasis Targets Ther20133110
- CeovicRManceMBukvic MokosZSvetecMKostovicKStulhofer BuzinaDPsoriasis: female skin changes in various hormonal stages throughout life – puberty, pregnancy, and menopauseBiomed Res Int2013201357191224459670
- ColomboDCassanoNBelliaGVenaGAGender medicine and psoriasisWorld J Dermatol2014333644
- ØstensenMVilligerPMFörgerFInteraction of pregnancy and autoimmune rheumatic diseaseAutoimmun Rev2012116–7A437A44622154710
- PoleseBGrideletVArakliotiEThe endocrine milieu and CD4 T-lymphocyte polarization during pregnancyFront Endocrinol (Lausanne)2014510625071722
- RaychaudhuriSPNavareTGrossJRaychaudhuriSKClinical course of psoriasis during pregnancyInt J Dermatol200342751852012839599
- MuraseJEChanKKGariteTJCooperDMWeinsteinGDHormonal effect on psoriasis in pregnancy and postpartumArch Dermatol2005141160160615897382
- BoydASMorrisLFPhillipsCMMenterMAPsoriasis and pregnancy: hormone and immune system interactionInt J Dermatol19963531691728655230
- MervicLManagement of moderate to severe plaque psoriasis in pregnancy and lactation in the era of biologicsActa Dermatovenerol Alp Pannonica Adriat2014232273124964946
- GudjonssonJEKarasonARunarsdottirEHDistinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients – an analysis of 1019 HLA-C and HLA-B-typed patientsJ Invest Dermatol2006126474074516439971
- ChoonSELaiNMMohammadNANanuNMTeyKEChewSFClinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, MalaysiaInt J Dermatol201453667668423967807
- LotemMKatzenelsonVRotemAHodMSandbankMImpetigo herpetiformis: a variant of pustular psoriasis or a separate entity?J Am Acad Dermatol1989202 Pt 23383412644321
- RothMMPregnancy dermatoses: diagnosis, management, and controversiesAm J Clin Dermatol2011121254121110524
- KondoRNAraújoFMPereiraAMLopesVCMartinsLMPustular psoriasis of pregnancy (impetigo herpetiformis) – case reportAn Bras Dermatol2013886 Suppl 118618924346915
- PatsatsiATheodoridisTDVavilisDCyclosporine in the management of impetigo herpetiformis: a case report and review of the literatureCase Rep Dermatol2013519910423626548
- SeegerJDLanzaLLWestWAFernandezCRiveroEPregnancy and pregnancy outcome among women with inflammatory skin diseasesDermatology20072141323917191045
- HarderEAndersenAMKamper-JørgensenMSkovLNo increased risk of fetal death or prolonged time to pregnancy in women with psoriasisJ Invest Dermatol201413461747174924463423
- Ben-DavidGSheinerEHallakMLevyAPregnancy outcome in women with psoriasisJ Reprod Med200853318318718441722
- Cohen-BarakENachumZRozenmanDZivMPregnancy outcomes in women with moderate-to-severe psoriasisJ Eur Acad Dermatol Venereol20112591041104721108670
- YangYWChenCSChenYHLinHCPsoriasis and pregnancy outcomes: a nationwide population-based studyJ Am Acad Dermatol2011641717720970879
- LimaXTJanakiramanVHughesMDKimballABThe impact of psoriasis on pregnancy outcomesJ Invest Dermatol20121321859121918537
- MarikPEHypertensive disorders of pregnancyPostgrad Med20091212697619332964
- BandoliGJohnsonDLJonesKLPotentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasisBr J Dermatol201016333433920545678
- BushMCPatelSLapinskiRHStoneJLPerinatal outcomes in inflammatory bowel diseaseJ Matern Fetal Neonatal Med200415423724115280131
- LinHCChenSFLinHCChenYHIncreased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population-based studyAnn Rheum Dis201069471571719406733
- RuizVManubensEPuigLPsoriasis in pregnancy: a review (I)Actas Dermosifiliogr2014105873474324182657
- HornEJChambersCDMenterAKimballABInternational Psoriasis CouncilPregnancy outcomes in psoriasis: why do we know so little?J Am Acad Dermatol2009612e5e819615534
- RamozLLPatel-ShoriNMRecent changes in pregnancy and lactation labeling: retirement of risk categoriesPharmacotherapy201434438939524390829
- LamJPolifkaJEDohilMASafety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseasesJ Am Acad Dermatol200859229531518410980
- PazianaKDel MonacoMCardonickECiclosporin use during pregnancyDrug Saf201336527929423516008
- LinHCHunnicuttJNMoustafaFAPharmacological treatments in pregnant women with psoriasis in the USABr J Dermatol2015172380781025070258
- BaeYSVan VoorheesASHsuSReview of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis FoundationJ Am Acad Dermatol201267345947722018758
- MarciniakBPatro-MałyszaJPoniedziałek-CzajkowskaEKimber-TrojnarZLeszczyńska-GorzelakBOleszczukJGlucocorticoids in pregnancyCurr Pharm Biotechnol201112575075721342122
- ChiCCLeeCWWojnarowskaFKirtschigGSafety of topical corticosteroids in pregnancyCochrane Database Syst Rev20093CD00734619588425
- ChiCCMayon-WhiteRTWojnarowskaFTSafety of topical corticosteroids in pregnancy: a population-based cohort studyJ Invest Dermatol2011131488489121191410
- HviidAMølgaard-NielsenDCorticosteroid use during pregnancy and risk of orofacial cleftsCMAJ2011183779680421482652
- ChiCCWangSHMayon-WhiteRWojnarowskaFPregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort studyJAMA Dermatol2013149111274128024005903
- SkuladottirHWilcoxAMcConnaugheyRVindenesHLieRTFirst-trimester nonsystemic corticosteroid use and the risk of oral clefts in NorwayAnn Epidemiol201424963564025127739
- ChiCCKirtschigGAbererWEvidence-based (S3) guideline on topical corticosteroids in pregnancyBr J Dermatol2011165594395221729030
- TylerKHZirwasMJPregnancy and dermatologic therapyJ Am Acad Dermatol201368466367123182064
- MuraseJEHellerMMButlerDCSafety of dermatologic medications in pregnancy and lactation: Part I. PregnancyJ Am Acad Dermatol2014703401.e1e1424528911
- WheelerLASapersteinMDLoweNJMutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet lightJ Invest Dermatol19817721811857276613
- KhanABourgeoisJMohidePAgnathia-otocephaly complex in a fetus with maternal use of topical 1% salicylateClin Dysmorphol2008171757618049088
- Nakhai-PourHRBérardAMajor malformations after first trimester exposure to aspirin and NSAIDsExpert Rev Clin Pharmacol20081560561624422733
- MenterAPharmacokinetics and safety of tazaroteneJ Am Acad Dermatol2000432 Pt 3S31S3510898827
- FranssenMEvan der WiltGJde JongPCBosRPArnoldWPA retrospective study of the teratogenicity of dermatological coal tar productsActa Derm Venereol199979539039110494722
- Tang-LiuDDMatsumotoRMUsanskyJIClinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment of acne and psoriasisClin Pharmacokinet199937427328710554045
- El-SaieLTRabieARKamelMISeddeikAKElsaieMLEffect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasisLasers Med Sci201126448148521344249
- RoseRFBatchelorRJTurnerDGouldenVNarrowband ultraviolet B phototherapy does not influence serum and red cell folate levels in patients with psoriasisJ Am Acad Dermatol200961225926219493587
- SternRSLangeROutcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen-photochemotherapy (PUVA) for the treatment of psoriasisArch Dermatol199112733473501998364
- GunnarskogJGKällénAJLindelöfBGSigurgeirssonBPsoralen photochemotherapy (PUVA) and pregnancyArch Dermatol199312933203237772086
- Park-WyllieLMazzottaPPastuszakABirth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studiesTeratology200062638539211091360
- Bay BjørnAMEhrensteinVHundborgHHNohrEASørensenHTNørgaardMUse of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspringAm J Ther2014212738023011170
- SkuladottirHWilcoxAJMaCCorticosteroid use and risk of orofacial cleftsBirth Defects Res A Clin Mol Teratol2014100649950624777675
- LamarqueVLeleuMFMonkaCKruppPAnalysis of 629 pregnancy outcomes in renal transplant recipients with SandimmuneTransplant Proc199729524809270819
- Bar OzBHackmanREinarsonTKorenGPregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysisTransplantation20017181051105511374400
- ArmentiVTMcGroryCHCaterJRRadomskiJSMoritzMJPregnancy outcomes in female transplant recipientsTransplant Proc1998305173217349723259
- HaleEKPomeranzMKDermatologic agents during pregnancy and lactation: an update and clinical reviewInt J Dermatol200241419720312031026
- AltomareGAyalaFBardazziFConsensus on the use of cyclosporine in dermatological practiceG Ital Dermatol Venereol2014149560762525213388
- MillsopJWHellerMMEliasonMJMuraseJEDermatological medication effects on male fertilityDermatol Ther201326433734623914891
- LarsenFGJakobsenPKnudsenJConversion of acitretin to etretinate in psoriatic patients is influenced by ethanolJ Invest Dermatol199310056236278491984
- VenaGACassanoNThe effects of alcohol on the metabolism and toxicology of anti-psoriasis drugsExpert Opin Drug Metab Toxicol20128895997222594656
- LloydMECarrMMcElhattonPHallGMHughesRAThe effects of methotrexate on pregnancy, fertility and lactationQJM1999921055156310627876
- HyounSCObicanSGScialliARTeratogen update: methotrexateBirth Defects Res A Clin Mol Teratol201294418720722434686
- LewdenBVialTElefantELow dose methotrexate in the first trimester of pregnancy: results of a French collaborative studyJ Rheumatol200431122360236515570635
- MartínMCBarberoPGroismanBAguirreMÁKorenGMethotrexate embryopathy after exposure to low weekly doses in early pregnancyReprod Toxicol201443262924513926
- GrunewaldSPaaschUGlanderHJSystemic dermatological treatment with relevance for male fertilityJ Dtsch Dermatol Ges200751152117229200
- GeigerJMBaudinMSauratJHTeratogenic risk with etretinate and acitretin treatmentDermatology19941891091168075435
- GeigerJMWalkerMIs there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane)?Dermatology2002205210510712218221
- HanJYChoiJSChunJMPregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretinJ Obstet Gynaecol200929869469719821659
- KaneSVAcquahLAPlacental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancyAm J Gastroenterol2009104122823319098873
- ØstensenMFörgerFHow safe are anti-rheumatic drugs during pregnancy?Curr Opin Pharmacol201313347047523522967
- MartinPLSachsCImaiNDevelopment in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactationBirth Defects Res B Dev Reprod Toxicol201089535136320540088
- ChambersCDJohnsonDLEmerging data on the use of antitumor necrosis factor-alpha medications in pregnancyBirth Defects Res A Clin Mol Teratol201294860761122786755
- MarchioniRMLichtensteinGRTumor necrosis factor-alpha inhibitor therapy and fetal risk: a systematic literature reviewWorld J Gastroenterol201319172591260223674866
- HyrichKLVerstappenSMBiologic therapies and pregnancy: the story so farRheumatology (Oxford)20145381377138524352337
- VerstappenSMKingYWatsonKDAnti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics RegisterAnn Rheum Dis201170582382621362710
- YarurAKaneSVUpdate on pregnancy and breastfeeding in the era of biologicsDig Liver Dis2013451078779423474350
- SheeranCNicolopoulosJPregnancy outcomes of two patients exposed to ustekinumab in the first trimesterAustralas J Dermatol201455323523625117169
- YiuZZGriffithsCEWarrenRBSafety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patientsBr J Dermatol2014171348549124749725
- CheentKNolanJShariqSKihoLPalAArnoldJCase report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn’s diseaseJ Crohns Colitis20104560360521122568
- PuchnerRDanningerKPuchnerAPieringerHImpact of TNF-blocking agents on male sperm characteristics and pregnancy outcomes in fathers exposed to TNF-blocking agents at time of conceptionClin Exp Rheumatol201230576576722935608
- Summary of product characteristicsEuropean Medicines Agency2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000262/WC500027361.pdfAccessed January 6, 2015
- Summary of product characteristicsEuropean Medicines Agency2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000958/WC500058513.pdfAccessed January 6, 2015
- Summary of product characteristicsEuropean Medicines Agency2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000240/WC500050888.pdfAccessed January 6, 2015
- Summary of product characteristicsEuropean Medicines Agency2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000481/WC500050870.pdfAccessed January 6, 2015